Results 141 to 150 of about 6,010 (179)

Epoprostenol

Reactions Weekly
  +12 more sources

Transitioning From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension

Chest, 2002
Continuous i.v. epoprostenol (prostacyclin) therapy improves survival and quality of life in patients with pulmonary arterial hypertension (PAH). i.v.
Nicholas Hill, Robert Naeije, Robyn J Barst   +2 more
exaly   +1 more source

Epoprostenol

Reactions Weekly, 2018
  +7 more sources

Epoprostenol

Reactions Weekly, 2022
openaire   +2 more sources

Epoprostenol

Reactions Weekly, 2016
  +5 more sources

Epoprostenol

Reactions Weekly, 2011
  +4 more sources

Epoprostenol

Reactions Weekly, 2017
  +4 more sources

Epoprostenol

Reactions Weekly, 2021
openaire   +2 more sources

Epoprostenol

Reactions Weekly, 1998
openaire   +1 more source

Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19

Journal of Intensive Care Medicine, 2021
C William Pike, Rajiv Sonti, Nathan Cobb   +2 more
exaly